Showing results (141-150 of 176) with videos related to
Sort By:
Pageof 18
Journal of Agricultural and Food Chemistry|September 2, 2011
Compositional variability in conventional and glyphosate-tolerant soybean (Glycine max L.) varieties grown in different regions in BrazilJie Zhou, Kristina H Berman, Matthew L Breeze, et al.Scientific Reports|August 6, 2021
Large-scale assessment of lepidopteran soybean pests and efficacy of Cry1Ac soybean in BrazilRenato J Horikoshi, Patrick M Dourado, Geraldo U Berger, et al.International Journal of Computer Assisted Radiology and Surgery|January 26, 2019
Interactive virtual 3D models of renal cancer patient anatomies alter partial nephrectomy surgical planning decisions and increase surgeon confidence compared to volume-rendered imagesE R Hyde, L U Berger, N Ramachandran, et al.Leukemia|June 24, 2000
Detection and quantification of residual disease in chronic myelogenous leukemiaA Hochhaus, A Weisser, P La Rosée, et al.Leukemia|August 30, 2002
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alphaK Merx, M C Müller, S Kreil, et al.Journal of Insect Science (Online)|March 8, 2024
Molecular characterization and demographic insights into soybean bud borer (Lepidoptera: Tortricidae) in BrazilDavi de Souza Fernandes, Renato Jun Horikoshi, Patrick M Dourado, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Prognostic significance of micrometastases in bone marrow in patients with primary breast cancerR C Coombes, U Berger, J Mansi, et al.British Journal of Cancer|April 17, 1999
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIcW Kuhn, B Schmalfeldt, U Reuning, et al.Leukemia|September 13, 2003
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remissionP Paschka, M C Müller, K Merx, et al.Blood|September 15, 1996
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemiaA Hochhaus, A Reiter, H Skladny, et al.Pageof 18